Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trigen makes two appointments

This article was originally published in Scrip

Executive Summary

Trigen (Germany), a drug development company developing biologics for use in antithrombotic therapy, has appointed Dr Ayad Abdul-Ahad chief executive officer and Dr Norbert Bender chief medical officer. Dr Abdul-Ahad joins from Biogen Idec, where he served as vice-president and head of international medical affairs; he has also worked at Berlex Laboratories, AstraZeneca, SmithKline Beecham and Serono. Dr Bender has more than 10 years' experience as a medical doctor and has more than 15 years' experience in pharmaceutical companies, having previously worked at Hoescht, BASF Pharma Knoll, Cardion and The Vaccines Company.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC031027

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel